FeaturedNeuroscience·July 24, 2026·9 min readFuture Obesity Drugs to Target Specific Brain CircuitsUsing site-specific knockout mouse models, researchers found that GIPR agonists suppress appetite via the brainstem, while GIPR antagonists act in the hypothalamus to release a "brake" on hindbrain satiety.Read More
FeaturedGeneticsNeuroscience·April 8, 2026·8 min readOzempic Weight Loss Success Varies by DNAA new study of 28,000 people identifies genetic markers in the GLP1R and GIPR genes that explain why some patients lose more weight or experience more nausea on GLP-1 drugs.Read More
